(none) 
Search for:
Limit by:
  Browse by Topic or Issue
Home Search/Browse Subscriptions PDA Services E-mail Alerts Customer Service
(none)

Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition).
Vol 22, No 14S (July 15 Supplement), 2004: 2087
© 2004 American Society of Clinical Oncology
This Article
Alert me when this article is cited
Alert me if a correction is posted
Services
Email this article to a friend
Similar articles in this journal
Download to citation manager
PubMed
Articles by John, G. N.
Articles by Kononas, T.

Abstract

Combined administration of hydrophilic antimitotic desoxyepothilone B and vinorelbine induce PUMA, suppression of microtubule dynamics, development of hypodiploidy and multinucleation, cell cycle perturbation at G2/M and apoptosis in advanced breast carcinoma (ABC) characterised by MDR-1 (Pgp),bcl-2 and mutant b-tubulin

G. N. John, J. Giannios, E. Michailakis, S. Konstandinidou, G. Xepapadakis, N. Alexandropoulos and T. Kononas

GSHA, Athens, Greece; BC, Athens, Greece; MH, Athens, Greece; IH, Athens, Greece

2087

Introduction: Low aqueous solubility of VRL is a high substrate for ATP dependent drug efflux proteins such as MDR-1(Pgp) and MRP2(ABCC2) inserted in plasma membrane of tumor cells.Furthermore,b-tubulin mutations are cross-resistant to VRL. Methods: We treat with MTC such as VRL and dEpoB advanced mammary carcinoma characterised by overexpression of bcl-2,MDR-1(Pgp),MRP2(ABCC2) and mutant b-tubulin according to PCR,WB and IHC analysis. MT polymerising agent dEpoB is more soluble in aqueous solvents than VRL reducing affinity for Pgp by being a poor substrate. Results: Post-treatment,although VRL and dEpoB are structurally unrelated,they bind to mutually exclusive sites on the tubulin unit.After binding of MTCs to MT,there was synergistic phosphorylation of bcl-2,overexpression of bax,circumvention of expression of altered b-tubulin polypeptides, MDR-1 and MRP-2 due to high hydrophilicity of dEpoB and PUMA. Flow cytometry showed blockage of cell proliferation at the metaphase-anaphase (G2/M) interface of the cell cycle.There was an enhancement in hypodiploid population of tumor cells,multinucleation,aberrant spindle formation,nuclear convolution,suppression of MT-dynamics and formation of MT bundling.Both drugs induced release of cyt-c from isolated mitochondria after interaction of mitochondrial tubulin with the voltage-dept anion channel of the permeability transition pore.There was potent immunosuppression by inhibiting T-cell proliferation.Methylene blue, BrdU and MTT exhibited inhibition of tumor cell proliferation. We observed nuclear factor kB-induced apoptosis displayed by features such as nuclear condensation and fragmentation,Annexin V staining,cleavage of poly(ADP-ribose)polymerase and activation of caspases. Conclusion: We observed synergy between dEpoB and vinorelbine in potentiation of apoptosis in advanced breast carcinoma circumventing chemoresistance.

No significant financial relationships to disclose.






About JCO Editorial Roster Advertising Information Rights & Permissions Site Map

Copyright © 2004 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
HighWire Press™ assists in the publication of JCO Online